Cellectar Biosciences (CLRB) Reports Strategic Collaboration with Onconova Therapeutics (ONTX) to Develop New PDCs
Tweet Send to a Friend
Cellectar Biosciences, Inc. (Nasdaq: CLRB), an oncology-focused, clinical stage biotechnology company (the “company”), and Onconova Therapeutics (Nasdaq: ONTX) today announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
